Table 3.
Summary of sample information
| Pancreatic cancer (n = 24) | Biliary tract cancer (n = 10) | Healthy control (n = 21) | |
|---|---|---|---|
| Age, year, mean ± SD | 62.8 ± 11.1 | 62.8 ± 7.8 | 43.9 ± 11.8 |
| Sex (%) | |||
| Male | 11 (45.8%) | 7 (70.0%) | 15 (71.4%) |
| Female | 13 (54.2%) | 3 (30.0%) | 6 (28.6%) |
| Diabetes (%) | 8 (33.3%) | 5 (50.0%) | 1 (4.8%) |
| Hypertension (%) | 12 (50.0%) | 3 (30.0%) | 1 (4.8%) |
| Smoking (%) | 4 (16.7%) | 5 (50%) | 0 (0.0%) |
| BMI, kg/m2, mean ± SD | 21.7 ± 2.9 | 23.2 ± 3.9 | 23.8 ± 3.8 |
| CA19–9, U/ml, mean ± SD | 3444.5 ± 6543.2 | 807.1 ± 1457.9 | 7.9 ± 6.9 |
| Tumor size, mm, mean ± SD | 31.2 ± 11.1 | 34.2 ± 26.5 | n/a |
| Stage (%) | |||
| I | 2 (8.3%) | 2 (20.0%) | n/a |
| II | 9 (37.5%) | 3 (60.0%) | n/a |
| III | 0 (0.0%) | 1 (10.0%) | n/a |
| IV | 13 (54.2%) | 4 (40.0%) | n/a |
| Recurrence after surgery (%) | 4/11 (36.4%) | 7/8 (87.5%) | n/a |
| DFS, median (range) | 10.5 (3.1–46.8) | 15.9 (2.1–44.1) | n/a |
| OS, month, median (range) | 15.2 (3.7–56.8) | 21.7 (2.8–44.7) | n/a |
Abbreviations: SD, standard deviation; BMI, body mass index; DFS, disease-free survival; OS, overall survival